Podcasts about Breast Cancer Care

In this episode of Our Womanity Dr. Rachel Pope sits down with Dr. Lily Gutnik, a breast surgeon and global health advocate dedicated to advancing equitable healthcare for women.Dr. Gutnik's journey is deeply rooted in her experience as a first-generation immigrant. After her parents fled religious persecution in the former USSR, she grew up in the United States, where she developed a profound appreciation for education and hard work. Her global perspective—shaped by extensive travel, multilingual abilities, and cross-cultural training—has reinforced her commitment to diversity, equity, and inclusion in healthcare.A firm believer in innovative, cross-disciplinary collaborations, Dr. Gutnik focuses on implementing high-quality, cost-effective breast cancer care, particularly for vulnerable women. She champions a convergence science approach to address the complex root causes of health disparities, using implementation science to develop interventions that drive health equity.For Dr. Gutnik, becoming a breast surgeon is more than a profession—it is a mission to empower women through health. Tune in as she shares her insights on building sustainable healthcare solutions, tackling systemic inequities, and the future of breast cancer care.Featured in this episode: Stigma around breast cancer and mistrust in the African and African American community Discovering Hands Initiative empowering blind women Uninsured and underinsured patients still face barriers to care Advancing breast cancer treatment in the US – But at what cost? Tanzania leading the charge in education, awareness, and stigma reduction Tuskegee Syphilis StudyFollow us on social media: Instagram: @drrpope TikTok: @vulvadoctor Twitter: @drrpope LinkedInWant more from Our Womanity?If you enjoyed this episode of Our Womanity, please subscribe, rate, and leave a review. Your feedback helps us continue to bring you engaging and empowering content.

In this episode of Onc Now, Jonathan is joined by Dr Dave Cescon, a Medical Oncologist and Clinician Scientist at the Princess Margaret Cancer Centre, Toronto, Canada. Together, they explore the transformative impact of CDK4/6 inhibitors, challenges in liquid biopsy research, and the potential of mRNA vaccines in oncology.  Timestamps: (02:44) -Swimming in Toronto: Competitive vs. Open Water  (08:06) -From Internal Medicine to Breast Cancer Research  (14:09) -Translational research and circulating tumour DNA  (19:53) -The role of CDK4/6 inhibitors in breast cancer  (29:04) -FDA approval of ribociclib for high-risk early breast cancer  (31:45) -The future of mRNA vaccines for personalised cancer care  (37:34) -Dave's research challenges and innovations  (39:13) -Three wishes for healthcare 

Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease?   Credit available for this activity expires: 1/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu

Watch hol+ by Dr. Taz MD on YouTube: https://www.youtube.com/@DrTazMD/podcastsThe incidence of breast cancer is rising and has now surpassed lung cancer as the leading cancer worldwide. This script features a comprehensive discussion between the host and Dr. Kristi Funk, a double board-certified breast cancer surgeon and lifestyle medicine doctor. The conversation covers the rising rates of breast cancer, key risk factors such as diet, exercise, and lifestyle choices, and the role of early detection and screening. Dr. Funk shares her personal experiences, insights on how younger and older women can reduce their risk, the impact of hormone replacement therapy, and the importance of lifestyle modifications. Additionally, advancements in breast cancer treatments, including immunotherapy and personalized medicine, are explored as hopeful developments in the fight against breast cancer.About Dr. Kristi FunkKristi Funk, M.D. is a double board-certified breast cancer surgeon, and lifestyle medicine doctor, bestselling author, and international speaker. She graduated from Stanford University in 1991, received her medical degree from UC Davis, completed her surgical residency in Seattle, and a breast cancer fellowship at Cedars-Sinai in Los Angeles. She excelled as a Director of the Cedars-Sinai Breast Center until 2009 when Dr. Funk co-founded the the Pink Lotus Breast Center in Los Angeles where she currently practices. She has helped thousands of women navigate breast issues, including celebrities like Angelina Jolie and Sheryl Crow. Dr. Funk's nutritional science expertise sparked twin passions: the online women's social network, Pink Lotus Power Up, and her annual in-person or virtual Cancer-Kicking! Summits. She is the go-to breast expert for Good Morning America and Dr. Phil's Merit Street Media; she was a co-host of The Doctors tv show, and has repeatedly appeared on Today, Rachael Ray, The Dr. Oz Show, CNN, The View, and more. She resides in Los Angeles, CA, with her husband and triplet sons.Thank you to our sponsorBiOptimizers:  bioptimizers.com/holplus04:36 Current Trends and Statistics in Breast Cancer08:10 The Role of Genetics and Lifestyle in Breast Cancer11:16 Diet, Exercise, and Environmental Factors36:49 The Impact of Emotional Health on Breast Cancer43:05 Breast Cancer Screening for Young Women49:30 The Debate on Mammograms and Ultrasounds52:22 Understanding DCIS: Overdiagnosis and Overtreatment1:00:24 Hormone Replacement Therapy and Breast Cancer01:15:24 Future of Breast Cancer Care and TreatmentStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Dr. Kristi Funk:https://www.instagram.com/drkristifunkhttps://pinklotus.com/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+

Advancing Breast Cancer Care for Hispanic Women with guest Dr. Monica Valero, January 19, 2025 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Following the 2024 San Antonio Breast Cancer Symposium (SABCS), Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD, co-hosted a live X Space with CancerNetwork® and spoke about updated trial findings that may impact the breast cancer treatment paradigm. Tarantino is a clinical research fellow at Dana-Farber Cancer Institute and Harvard Medical School. Lambertini is an associate professor and consultant in medical oncology at the University of Genova – IRCCS Policlinico San Martino Hospital in Genova, Italy. Tarantino and Lambertini highlighted data from various studies that investigators presented at the Symposium, which included results on the use of treatment modalities such as antibody drug conjugates and CDK4/6 inhibitors. Some presentations of interest included the following: ·      Phase 3 DESTINY-Breast06 Trial (NCT04494425) o   Patients with hormone receptor (HR)–positive, HER2-low or HER2-ultralow metastatic breast cancer were assigned to receive fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) or physician's choice of therapy. o   Treatment with T-DXd improved progression-free survival (PFS) among patients with a time to progression on frontline endocrine therapy of less than 6 months (HR, 0.38; 95% CI, 0.25-0.59), 6 to 12 months (HR, 0.69; 95% CI, 0.43-1.12), and more than 12 months (HR, 0.67; 95% CI, 0.51-0.88). o   PFS improved with T-DXd regardless of disease burden. ·      Phase 3 EMBER-3 Trial (NCT04975308) o   Investigators evaluated 3 treatment arms—imlunestrant (LY3484356) monotherapy, fulvestrant (Faslodex) or exemestane (Aromasin), and imlunestrant in combination with abemaciclib (Verzenio)—among patients with estrogen receptor (ER)–positive, HER2-negative advanced breast cancer. o   Across the overall population, imlunestrant monotherapy improved PFS compared with standard endocrine therapy (HR, 0.87; 95% CI, 0.72-1.04; P = .12). o   Imlunestrant plus abemaciclib also showed a PFS improvement vs endocrine therapy across the overall population (HR, 0.57; 95% CI, 0.44-0.73; P

Evgenia Koutsouki, EMJ Editor, reflects on the most memorable moments from the EMJ Podcast over the past year in this festive highlight's episode. Throughout 2024, our podcast has featured an impressive lineup of guests discussing groundbreaking topics, including advancements in breast cancer care, the evolving landscape of heart failure treatment, revolutionary approaches to prostate disease management, and much more. Join us this holiday season as we celebrate the best conversations and insights from an incredible year in healthcare!  Timestamps:  (00:00)-Introduction   (01:00)-Advancing breast cancer care   (05:52)-The hidden drivers of hunger and weight   (12:12)-The evolving landscape of heart failure treatment   (16:24)-Revolutionising prostate disease management   (21:18)-Sepsis – the silent killer   (26:46)-Individualised prostate cancer care   (31:22)-Wrap up     Featured Episodes:  Advancing Breast Cancer Science and Patient Care   Endocrinology: The Hidden Drivers of Hunger and Weight  Heartbeats and High Achievements  Revolutionising Radiology: Innovations and Advances in the Field  The Silent Killer: Spotlight on Sepsis  Breaking Barriers in Urologic Oncology 

In this enlightening episode of The Patient From Hell podcast, Dr. Doug Blayney and host Samira Daswani dive deep into the key insights from the 2024 San Antonio Breast Cancer Symposium (SABCS). They explore four critical areas of breast cancer care: CDK4/6 inhibitors, antibody-drug conjugates (ADCs), de-escalation strategies for ductal carcinoma in situ (DCIS), and the emerging role of artificial intelligence in cancer diagnostics. Throughout the conversation, a central theme emerges: the increasing ability to personalize cancer treatment, considering individual patient characteristics, biological markers, treatment options, and personal goals for quality and quantity of life. Key Highlights: 1. Biomarkers are becoming increasingly sophisticated, allowing for more precise and personalized treatment approaches across different breast cancer subtypes. 2. Patient choice and individual considerations are paramount, with treatment decisions now focusing on balancing potential survival benefits against quality of life impacts. 3. Emerging technologies like antibody-drug conjugates and artificial intelligence are revolutionizing breast cancer care by offering more nuanced, targeted diagnostic and treatment options. About our guest: Dr. Doug Blayney is an oncology physician who specializes in breast cancer and the Chief Medical Officer of Manta Cares. His research focuses on quality improvement in cancer care systems, new drug development, and patient experience improvement. At the American Society of Clinical Oncology (ASCO), he was founding Editor-in-Chief of its flagship practice journal, and as President, started the ASCO Quality Symposium and began planning for ASCO's CancerLinq. He was a founding member of the National Comprehensive Cancer Network (NCCN) Growth Factor Guideline panel, and is a past member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee and the NCCN Board of Directors.  Key Moments: At 38 minutes: "There's a company now that has a gene expression panel that may predict, and it looks like it does predict, whether radiation treatment after standard treatment for DCIS is beneficial. So if this predicted biomarker of benefit for radiation pans out, and I think it probably will, that means that we can deescalate or personalize whether radiation treatment and its side effects are likely to be beneficial to that patient." At 45 minutes: "Quality of life, can that be answered by a nine question questionnaire? Well, maybe. If you can't get out of bed, your quality of life is because something hurts or if your arm doesn't work because they're so swollen, that's one extreme... What about 15 years playing that duet? What about three? It's those kind of subtleties that we need to take into account." At 49 minutes:"AI can interpret mammograms. The images from a mammogram 20 years ago, there were four, top, bottom, side, side, and maybe another oblique. And now there's 60 images from a mammogram. So that means that a radiologist, a human radiologist, whether it's next door or around the world, somebody needs to look at those. AI can help." Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only.  This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Send us a textDr. Colleen O'Kelly-Priddy, our esteemed guest with an impressive track record in breast surgical oncology, shares her passionate journey and mission to revolutionize breast cancer care at Renown in Reno, Nevada. With October designated as Breast Cancer Awareness Month, Dr. O'Kelly-Priddy enlightens us on the critical importance of screening mammograms and breast self-awareness. She also introduces the groundbreaking Conrad Breast Center, which promises comprehensive care with integrated surgical, medical, and imaging services, setting a new standard in the region.Navigating the complexities of post-cancer life, especially in terms of hormone management, is crucial for breast cancer survivors, and this episode offers valuable insights. We tackle the challenges of securing regular screenings and the power of centralized care facilities like the Conrad Breast Center in aiding seamless healthcare communication. Dr. O'Kelly-Priddy provides expertise on hormone replacement therapy and the use of biomarkers, ensuring survivors make informed, personalized decisions about their health. The episode also touches on the revolutionary oncoplastic surgery approach, blending cancer-removal techniques with plastic surgery for enhanced post-surgical outcomes.The conversation doesn't stop at medical treatments; it extends to holistic care and community support. For those grappling with the emotional and practical challenges of a breast cancer diagnosis, essential resources like the Nevada Cancer Coalition and Community Health Alliance are spotlighted for their supportive roles. Breast 360 - a reliable resource for breast patients written by breast surgeons   www.breastcancer.org Donate here to the Breast Imaging Fund:https://www.renown.org/About/Renown-Health-Foundation/Secure-Online-DonationSelect “Renown Breast Imaging Fund” from the drop-down menuNevada Cancer Coalition  Are you loving the Test Those Breasts! Podcast? You can show your support by donating to the Test Those Breasts Nonprofit @ https://testthosebreasts.org/donate/ Where to find Jamie:Instagram LinkedIn TikTok Test Those Breasts Facebook Group LinkTree Jamie Vaughn in the News! Thanks for listening! I would appreciate your rating and review where you listen to podcasts!I am not a doctor and not all information in this podcast comes from qualified healthcare providers, therefore may not constitute medical advice. For personalized medical advice, you should reach out to one of the qualified healthcare providers interviewed on this podcast and/or seek medical advice from your own providers .

Jennifer Johnson, Founder and CEO of JennJ Health and Fitness, talks with EisnerAmper's TechTalk host Janina Teoxon about her remarkable journey from being a cancer patient to launching a startup that's focused on closing the health equity gap for all patients. In this episode, discover how Jennifer is leveraging an innovative AI-driven fitness solution for breast cancer patients, empowering them with data that can positively influence their medical treatment. Tune in to gain valuable insights from Jennifer on applying for grant funding, and learn what success truly means to her.

Love the episode? Send us a text!In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Stephanie S. Abbott, a remarkable individual who has navigated the complex worlds of both healthcare administration and cancer survivorship. Stephanie brings a unique perspective, having served in multiple leadership roles in healthcare, including Chief Experience Officer for Adventist Health and Division Vice President of Patient Experience for HCA.Stephanie shared her personal journey, from her diagnosis on November 12, 2021, to her experiences as a patient undergoing treatment. She highlighted the emotional and operational challenges she faced, offering invaluable insights into the friction points within the healthcare system. Stephanie's story underscores the importance of human connection and effective communication between patients and healthcare providers.Stephanie is also the author of the book Buried or Planted: 100+ Expert Insights from a Healthcare Executive's Journey as a Cancer Patient on Amazon below: https://www.amazon.com/Buried-Planted-Insights-Healthcare-Executives/dp/B0D4Q9QM78SURVIVINGBREASTCANCER.ORGAttend a free virtual SurvivingBreastCancer.org event:https://www.survivingbreastcancer.org/eventsFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.https://www.survivingbreastcancer.org/takeahikeSupport the show

In honor of Breast Cancer Awareness month – 25 weeks post surgery and outrageously grateful to be cancer free – Amanda revisits an episode from the messy middle of her breast cancer diagnosis. In this raw conversation, she talks candidly through her fears while trying to figure out what really matters for her health and life. This is a powerful conversation to share with any breast cancer survivor anyone in the messy middle of battling it now.  To listen to the first part of this conversation with Amanda, go to: Episode 309 Amanda's Diagnosis & What's Next (Pt. 1). And for more episodes on Breast Cancer Awareness, please also check out:  Episode 316 Amanda Returns Post Surgery: Here's What She Wants You To Know Episode 317 What Amanda's Learned About Life, Love & Community (Post Surgery Pt 2)  Episode 320 Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem Episode 321 Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In this empowering episode, we sit down with Pam Kohl, Patient Advocate, to explore the critical role trusting your intuition when receiving health care. Pam shares her personal journey from an early breast cancer diagnosis to living with metastatic breast cancer, revealing her remarkable resilience and determination. Her story underscores the importance of trusting your instincts, advocating thorough testing, and staying informed to navigate the complexities of the healthcare system effectively.Find out how you are the best advocate for your health outcomes. Listen to the episode and discover:Navigating the Challenges of Breast CancerPam Cole's story is one of resilience and determination. After initially being diagnosed with stage 1 ER+ breast cancer in 2009, she underwent a lumpectomy, radiation, and five years of endocrine therapy. Despite being told she was cured, Pam faced a recurrence of her cancer, which eventually led to a metastatic diagnosis. The Power of Knowledge and Self-AdvocacyThroughout the episode, Pam emphasizes the necessity of understanding diagnostic tools and the need to demand comprehensive testing, such as PET scans, when necessary. Advancements in Breast Cancer Care and Nuclear Medicine SafetyThe conversation extends beyond personal experiences, touching on advancements in breast cancer management, particularly for ER+ cases. HER HEALTHX Improving Health Outcomes for WomenThe conversation explores the implications of medical gaslight and how HER HEALTHX, a nonprofit organization is dedicated to addressing the broader impact of medical gaslighting on women and their communities.3 Takeaways:Feel Empowered: When you understand your diagnosis and the available medical options is crucial for effective self-advocacy. Ask questions and don't be afraid to make choices that align with your instincts.Safety in Nuclear Medicine: The conversation sheds light on the importance of safety standards in medical testing and the advocacy needed to improve these practices. Support H.R.6815 — 118th Congress (2023-2024)Community Impact: Addressing how medical gaslighting affects not just the individual but the wider community."You need to be paying attention to your body and trusting your intuition. Trust yourself and advocate for yourself. It's the most important thing you can do."-Pam KohlThank you Pam for sharing your story. Join Pam Kohl and host Natalie Benamou on October 23rd for a panel discussion about Extravasation and Step Therapy at 11 AM CT/ 12 PM ET.Register hereResources:https://www.safernuclearmedicine.org/American Cancer SocietyHER HEALTHXAbout Pam KohlPam Kohl, a North Carolina native with over 40 years of experience in government and nonprofit management, has dedicated her career to breast cancer advocacy. As the former Executive Director of Susan G. Komen's North Carolina Triangle to the Coast Affiliate, she advocated for equitable breast cancer support and research across 29 counties. Pam directed the Komen Metastatic Breast Cancer Collaborative Research Initiative, focusing on finding treatments and cures, especially after her own battles with breast cancer. Diagnosed initially in 2009 with Stage 1 ER+ breast cancer and declared cancer-free in 2014, she faced a recurrence in 2016 and was diagnosed with Stage IV metastatic breast cancer in 2017. Her treatment regimen includes Verzenio, Fulvestrant, and regular scans.Connect with Host Natalie Benamou, Founder HerCsuite®Natalie Benamou is the host of "Women Leaders on the Move '' and the Founder of HerCsuite®, a powerful women's network providing connect circles for women's careers and businesses. She is dedicated to making it easier for women to achieve success in all aspects of their lives. Natalie is also the Founder and President of HER HEALTHX, a nonprofit on improving health outcomes for women.Natalie Benamou on LinkedInHerCsuite® on LinkedIn

Struggling with weight gain during menopause or curious about how cannabis can ease your symptoms? You're not alone. Today on Gyno Girl Presents: Sex, Drugs, and Hormones, join us as we unpack these topics with Dr. Becky Lynn, a leading gynecologist and menopause expert from Evora Health. Discover groundbreaking treatments and real talk on women's health that you won't want to miss.Dr. Lynn shares her journey into the specialized field of sex med, revealing the gaps in medical training that drove her to become a leading voice in women's sexual health. She discusses her innovative approaches to treating menopausal symptoms and sexual health problems, integrating her deep medical expertise with practical advice.Our conversation today covers a range of topics, from the challenges of obesity medicine in menopausal women to groundbreaking research on cannabis use for sexual enhancement. Dr. Lynn's insights are not only informative but also deeply empowering, offering hope and new possibilities for women struggling with these complex issues.HighlightsInnovative Approaches: Dr. Lynn discusses how she uses her expertise in obesity medicine to address weight management in menopausal women, integrating treatments like GLP-1 agonists.Sexual Medicine Insights: Explore how Dr. Lynn helps her patients navigate sexual health challenges during menopause, using both medical and counseling strategies.Cannabis Research: Dr. Lynn shares fascinating insights into her research on the effects of cannabis on sexual function, providing a nuanced view of its benefits.Educational Empowerment: Dr. Lynn emphasizes the importance of education and advocacy in overcoming the stigmas associated with sexual and reproductive health.Do you have questions about menopause or sexual health you're hesitant to ask? Join our conversation and empower yourself with knowledge. Subscribe to our podcast, leave a review, and follow us on social media to stay updated with expert insights and supportive community discussions. Let's change the way we talk about women's health together!Guest Bio:Dr. Becky Lynn is the Founder and CEO of the Evora Women's Health as well as an AdjunctAssociate Professor of Obstetrics and Gynecology at Saint Louis University.Dr. Lynn is a leader in the women's health and cannabis space. Her research focuses on theeffects of cannabis on sexual function in women. She has published papers in the scientificliterature and has presented her research both nationally and internationally. Dr. Lynn has beenfeatured in numerous podcasts and several articles in the cannabis space. Her The Relationshipbetween Marijuana Use Prior to Sex and Sexual Function in Women and Effects of Cannabinoidson Female Sexual Function can be found online.Dr. Lynn completed medical school at Georgetown University School of Medicine inWashington, DC, completed her residency at Washington University in St. Louis, and practicedat the University of Missouri, Columbia before joining the faculty at Saint Louis University in2015 where she was full time faculty until 2020. After leaving SLU, she founded the EvoraWomen's Health in February 2020. In addition, she completed her sexual counselor training atSexual Medicine Associates in Florida and she completed her MBA at Saint Louis University. Dr.Lynn enjoys running, foreign language and travel. She once rode her bicycle from London toParis to raise money for Breast Cancer Care.Get in Touch with Dr. LynnWebsite

Christine Brezden-Masley, MD, PhD, FRCPC - Navigating HER2+ Early Breast Cancer Care: A Multidisciplinary Roadmap to Better Survival

Christine Brezden-Masley, MD, PhD, FRCPC - Navigating HER2+ Early Breast Cancer Care: A Multidisciplinary Roadmap to Better Survival

Christine Brezden-Masley, MD, PhD, FRCPC - Navigating HER2+ Early Breast Cancer Care: A Multidisciplinary Roadmap to Better Survival

On this episode of The Mid.Point, Gabby is joined by Model and TV and radio presenter Lisa Snowdon. Lisa got spotted by a talent scout at aged just 19, and quickly became one of the UK's top models, known for high fashion covers such as Vogue, and beauty adverts too. Lisa's move into TV was in 2006, when she was announced as the Head Judge of ‘Britain's Next Top Model'. In 2008, she appeared on Strictly Come Dancing - the same year she began co-hosting the Capital London Breakfast Show (initially with Jonny Vaughn, and later with Dave Berry). She finished her early morning stint in 2015. On top of all the TV and modelling work she does, Lisa also finds time to be an Ambassador for Breast Cancer Care and The Meningitis Trust.Lisa is very honest and open about her menopause and the challenges she's had with HRT. She also talks about the imposter syndrome she has faced and overcome in her career, the early days of modelling and the gratitude she feels now, for how her life has turned out.We hope you enjoy the chat! Hosted on Acast. See acast.com/privacy for more information.

“I think the antibody-drug conjugates (ADCs) for physicians, and certainly patients too, are a little bit tough to wrap your head around,” says Erika P. Hamilton, MD, the director of breast cancer and gynecologic cancer research at Sarah Cannon Research Institute in Nashville. She discusses how TROP2-targeting ADCs currently fit into practice with Robert A. Figlin, MD, the Steven Spielberg Family Chair in Hematology-Oncology at the Cedars-Sinai Cancer Center in Los Angeles. From how to “choose the right patient for the right treatment at the right time” to important toxicity concerns, Dr. Hamilton shares her “elevator pitch” to patients when it comes to ADCs. “I think a very easy way to really talk about the activity at this point is just the fact that they're beating naked chemotherapy. So they are performing better than chemotherapy and, for the most part, comparing favorably in terms of side effects for patients as well.” Dr. Hamilton reported various financial relationships. Dr. Figlin reported various financial relationships.

The CNSA are excited to celebrate the inaugural Cancer Nurses Day 2024! We explore the invaluable impact that Cancer Nurses have on the patient experience and how the impact reaches beyond the physical to emotional support, educational resourcing, and even navigating the hospital ecosystem. Julie McCrossin AM, radio broadcaster, journalist and cancer survivor herself, shares her experiences with three consumers who have experience being treated in the oncology setting across Australia: Melissa Lewis, Head of Medical Partnerships at MooGoo SkinCare, Maria Waton, McGrath Breast Cancer Specialist Nurse, Clinical Lead in Breast Cancer Care and Clinical Lead for McGrath in WA; as well as Vince Severino from Sydney.

In this episode of Superwoman Wellness, we tackle the profound issue of breast cancer with the remarkable Dr. Jenn Simmons, author of the book The Smart Woman's Guide to Breast Cancer, a leading breast surgeon and integrative oncologist. Dr. Jenn was Philadelphia's first fellowship-trained breast surgeon, spending 17 years as the city's top expert. Her own health journey led her to discover the power of functional medicine, inspiring her to leave traditional practice in 2019 and found Real Health MD. Dr. Jenn is now pioneering new technologies and holistic approaches to help women truly heal along their breast cancer journeys.Join us as Dr. Jenn shares her unique insights on breast cancer prevention, diagnosis, and treatment. Dr. Jenn is currently opening PerfeQTion Imaging centers across the country featuring QT Imaging, an innovative technology that uses sound waves to create a 3D reconstruction of the breast without pain, compression, or radiation. —and discover the critical role of functional medicine in treating and preventing breast cancer.Today on Superwoman Wellness:Dr. Jen's transition from traditional breast surgeon to integrative oncologist.The impact of functional medicine in transforming breast cancer care.Debunking common myths about breast cancer diagnosis and treatment.The revolutionary QT imaging technology for safer breast cancer screening.The critical importance of addressing toxins, stress, and lifestyle in breast cancer prevention.Why DCIS (Ductal Carcinoma In Situ) is not breast cancer and how it should be treated.How hormone replacement therapy can play a role in post-cancer recovery.Empowering women to make informed decisions about their breast health.This show is supported by:EastWest - Use code SWW30 to get 30% off at theeastwestway.com.Follow Dr. Jenn Simmons: Website: Real Health MD Social Media: @drjennsimmons Book: The Smart Woman's Guide to Breast Cancer available on Amazon. Podcast: Keeping Abreast with Dr. JennQT Imaging: PerfeQTion ImagingFollow Dr. Taz:YouTube: @DrTazMDInstagram: @drtazmdWebsite: doctortaz.comCheck out "The Hormone Shift" book at prh.comthehormoneshiftThis Show is produced by ▶︎GOSTEK.media

Breast cancer is the most common cancer in the UK, accounting for 15% of all new cancer cases. In this episode, MIMS Learning editor Sangeeta Krishnan speaks to consultant medical oncologist Dr Jay Naik about the GP's role in breast cancer screening and red flags, and the management breast cancer. Discussing a memorable case, Dr Naik touches upon the importance of team effort in dealing with complex scenarios, and the far-reaching impact of cancer on the friends and families of patients.You can access the website version of this podcast on MIMS Learning to make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.Useful linksFurther learning on MIMS LearningBreast pain - red flag symptomsEarlier cancer diagnosisGuidance update: latest NICE guidelines on recognition and referral of suspected cancerExplaining genomic profiling results in breast cancerWhy do adverse events occur in immunotherapy?Managing the oncology patient's expectationsRegister to access contentRegister for a free MIMS Learning healthcare professional account Hosted on Acast. See acast.com/privacy for more information.

In this episode of Breast Cancer Conversations, we delve into the critical topic of nuclear medicine and its role in breast cancer diagnosis and treatment. As a breast cancer survivor and advocate, I understand the anxiety that comes with scans involving radioactive tracers. Today, we aim to demystify this process and highlight its importance.I am joined by Dr. Kiser and Pam Kohl, who provide insights from both medical and patient advocate perspectives. We discuss the safety and precautions associated with nuclear medicine tests, particularly focusing on the issue of extravasation—when the radioactive material leaks into surrounding tissues instead of staying in the vein.Throughout the episode, we stress the importance of patient advocacy and being informed about the procedures and technologies available. We hope this conversation empowers our listeners to ask the right questions and seek the best possible care.SURVIVINGBREASTCANCER.ORGAttend a free virtual SurvivingBreastCancer.org event:https://www.survivingbreastcancer.org/eventsFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.Support the Show.

In this episode of Breast Cancer Conversations, we had the pleasure of speaking with Dr. Laura James, a naturopathic oncologist based in Washington State. Dr. James provided a wealth of information about the role of naturopathic oncology in breast cancer care, emphasizing the importance of integrative medicine. She clarified the distinctions between integrative, complementary, and alternative care, and highlighted the collaborative approach she takes with conventional medical teams to support patients through their cancer journey.We discussed the critical role of the "four cornerstones" of health—diet, exercise, sleep, and stress management—in supporting overall well-being and reducing the risk of cancer recurrence.We also delved into the emotional and psychological aspects of a breast cancer diagnosis, particularly the societal pressures and internalized guilt that many women face. Dr. James emphasized the need for setting boundaries and practicing real self-care, which she defines as self-preservation; it is not selfishness. Throughout our conversation, Dr. James highlighted the importance of building a comprehensive care team and the challenges of integrating naturopathic oncology into conventional cancer care. She shared her experiences in developing relationships with conventional doctors and the ongoing effort to gain acceptance for integrative approaches.This episode is a must-listen for anyone looking to understand the holistic approach to breast cancer care and the importance of addressing both the physical and emotional aspects of the disease. Dr. James's expertise and compassionate approach offer valuable insights for patients, caregivers, and healthcare providers alike.Attend a free virtual SurvivingBreastCancer.org event:https://www.survivingbreastcancer.org/eventsFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.Support the Show.

Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001283?ecd=bdc_podcast_libsyn_mscpedu

From ASCO 2024.   When it comes to the use of antibody-drug conjugates (ADCs) in breast cancer care, "we're past the inflection point," says Hope S. Rugo, MD, a breast cancer oncologist and professor of medicine in the Division of Hematology and Oncology at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center. 

321. Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem Dr. Rachel Brem is back to discuss genetic testing for breast cancer risk, systemic issues within the medical establishment, guidance for those with dense breasts, and practical advice on MRI and mammograms. Plus, we'll hear some of the heartfelt and inspiring messages you've left us since you learned of Amanda's diagnosis.  Discover:  -The shocking statistic about who is most susceptible to breast cancer; -Why every doctor has a bias and what to do about it; -The truth about “overdiagnosis”; and  -How to get genetic testing and what to do with the information you receive. On Dr. Rachel Brem: Dr. Rachel Brem is the author of No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You. Dr. Brem is an internationally known breast cancer expert who has been instrumental in developing and implementing new technologies to improve breast cancer detection. She is Professor and Director of Breast Imaging and Intervention at George Washington University, Vice Chairman of the Department of Radiology, and Chief Medical Advisor and Cofounder of the Brem Foundation. She is a Fellow of the American College of Radiology and the Society of Breast Imaging. Find our first episode with Dr. Brem here: 320. Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

320. Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem Amanda shares an update on her recovery from breast cancer. Then, renowned breast cancer expert, Dr. Rachel Brem, joins the conversation to discuss the critical importance of early detection, breast density's impact on mammography, and when we need additional screenings.  Discover:  -The differing guidance on screenings and the truth about how often you should actually get screened for cancer; -Advice on what to say to your doctors to make sure that you get the screening you need and so that they can be covered under insurance; and -How to learn how dense your breasts are and what to do with that information.  On Dr. Rachel Brem: Dr. Rachel Brem is the author of No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You. Dr. Brem is an internationally known breast cancer expert who has been instrumental in developing and implementing new technologies to improve breast cancer detection. She is Professor and Director of Breast Imaging and Intervention at George Washington University, Vice Chairman of the Department of Radiology, and Chief Medical Advisor and Cofounder of the Brem Foundation. She is a Fellow of the American College of Radiology and the Society of Breast Imaging. Find more resources at The Brem Foundation Website: https://www.bremfoundation.org/  Check out Dr. Brem's Book, No Longer Radical: https://www.nolongerradical.com/ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Jessica Balidad, a remarkable woman who has turned her personal experience with breast cancer into a powerful advocacy platform. Jessica, a five-year survivor of stage 2B invasive ductal carcinoma, shared her journey from diagnosis to becoming a passionate advocate for women's health.Jessica's story is both inspiring and educational. She discovered her cancer through a self-breast exam, a practice she had been diligent about since having a benign tumor removed in college. Despite her family history of breast cancer, she faced challenges in getting her concerns taken seriously by medical professionals, highlighting the importance of self-advocacy and awareness.Jessica's experience led her to create the Feel For Your Life app, a free mobile application designed to educate women on how to perform self-breast exams, track changes and set reminders for regular checks. The app also includes a new AI feature, Breastfriend AI, which helps users understand their medical reports and prepare questions for their doctors, making the often overwhelming medical information more accessible and less intimidating.We also discussed the broader implications of breast cancer awareness and education, particularly among younger populations. Jessica has been instrumental in legislative efforts to include self-exam education in high school curriculums in Tennessee, aiming to empower the next generation with the knowledge to take control of their health.Additionally, Jessica shared insights into navigating the complexities of medical insurance, offering practical advice on how to handle claim rejections and advocate for necessary treatments.This episode is a testament to the power of turning personal pain into a purpose-driven mission. Jessica's work through Feel For Your Life is making a significant impact, providing essential tools and support for those affected by breast cancer.Attend a free virtual SurvivingBreastCancer.org event:https://www.survivingbreastcancer.org/eventsFollow us on InstagramLaura and Will: https://www.instagram.com/laura_and_will/SurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.Support the Show.

On National Clinical Trials Day, we're joined by my dear friend Ricki Fairley. She's the founder of Touch, The Black Breast Cancer Alliance, and a 13-year triple-negative breast cancer survivor.  Ricki shares her journey, highlighting disparities faced by Black women in breast cancer care. We discuss the vital need for inclusivity in clinical trials, stressing their importance for everyone.  

A huge thank you to our partners Oxford Hormone Clinic for helping us get this episode out to all of you! Their support means so much to us. All their details are in the show notes below. Ever wondered if collagen is safe for you? There is a lot of talk about collagen out there and some people say it really helps them with their skin, joints and even energy levels. And then we hear stories of concern as collagen has been linked to cancer. In today's episode, I am joined by Dr. Nina Fuller Shavel to answer this once and for all. So that we know the facts to make empowered choices for ourselves.You can find Dr. Fuller-Shavel here https://www.drninafullershavel.com/Her new book “Integrative Oncology in Breast Cancer Care' can be found HERE.Download your FREE Getting Started Guide here: https://menopauseandcancer.org/getting-started-guide/Episode highlights:00:00 Intro04:53 Collagen benefits for joint and skin health.08:04 Long-term safety unknown; worth trialling cautiously.10:08 Vegan supplements may support collagen, but unproven.16:06 Dietary amino acids impact collagen production differently.17:11 Taking collagen during cancer treatment, consult your doctor.24:42 Diverse toolkit for joint health including Rosehip.27:41 Empowerment comes from variety.Thank you to our sponsors of this episode: https://www.oxfordhormoneclinic.com/The team at The Oxford Hormone Clinic are passionate in helping people with a history of cancer. They are a holistic clinic focusing on informed choice regarding all aspects of menopause care; from lifestyle advice, over the counter supplements, to Body Identical Hormone replacement, always based upon British Menopause Society (BMS) and NICE guidelines.About Dani:The Menopause and Cancer Podcast is hosted by Dani Binnington, menopause guide, patients advocate for people in menopause after a cancer diagnosis, and founder of the online platform Healthy Whole Me. There is lots of information out there about the menopause but hardly any if you have had a cancer diagnosis as well. Many people say to me they have no idea what their options are, who to ask for help, and that they feel really isolated in their experiences. I started this podcast because there was nothing out there when I was thrown into surgical menopause at the age of 39, which followed on from my cancer diagnosis aged 33.Through the episodes, I want to create more awareness, share information from our fabulous guest experts, doctors and other specialists in the cancer and menopause field. And of course, I will share stories from the people in our community.So that together we can work towards a better menopause experience. For all of us.More educated, better informed and less alone.Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group:

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women's oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.

More women are surviving breast cancer than ever before yet, the statistic remains that breast cancer is the second leading cause of cancer death in women. In this episode, Dr. Abi Siva, a MUSC Health breast oncologist, explains the latest offerings in treatment and early detection from MUSC Hollings Cancer Center, that are helping more women live longer, healthier lives after a breast cancer diagnosis.

In this episode, we are joined by Dr. Ames Smith, a renowned breast cancer surgeon specializing in hereditary and genetic work with breast cancer. Dr. Smith shares his journey and how he became interested in hereditary cancer. He discusses the importance of testing for mutations and the high risk it poses for developing certain cancers. Dr. Smith also talks about his work at the Hereditary Cancer Risk Clinic and how he advises and follows up with patients who have mutations. He emphasizes that hereditary cancer is not limited to breast cancer and discusses other types of hereditary cancers such as colon, ovarian, uterine, brain, and kidney.Time Stamps with Key Takeaways:(03:34) Openness to genetic testing.(09:23) Ovarian cancer screening reliability.(13:19) Mammography and mortality reduction.(24:34])Diagnostic tools and stages.(27:35) Imaging can be wrong.(32:09) Thermography and breast cancer detection.(36:00) Breast cancer treatment advancements.(38:19) Improving functional quality of life.

In episode 62 of the Summits Podcast, Vince Todd, Jr. is joined by Lisa Hayes of Gennesaret Free Clinic and Pink-4-Ever Ending Disparities. Tune in as Lisa shares her personal triple-negative breast cancer story and her passion for fighting disparities in breast cancer care and treatment. For more on Pink-4-Ever Ending Disparities, visit pink-4-ever.org. Subscribe to the audio version of the Summits Podcast https://summitspodcast.fireside.fm Find out more about the Heroes Foundation https://www.heroesfoundation.org Find out more about The Brookfield Group https://thebrookfieldgroup.com Discover Platform 24 co-working https://www.platform24.co What's your cancer story? Hosted by cancer survivor and philanthropist Vince Todd, Jr., Chairman and Co-Founder of the Heroes Foundation, and Heroes Foundation Board Member Daniel Abdallah, the Summits Podcast is a place for people to share their stories. Everyone has a cancer story. From battling a deadly disease to caring for a loved one, when we rise up and face life's greatest challenges, we see with a new vision, feel with a greater passion, and think with a deeper perspective. Along the way, paths cross, journeys intersect, and missions converge. For Vince Todd, it was his own cancer diagnosis that led him and his wife, Cindy, to launch the Heroes Foundation to provide meaningful support to cancer patients, education to promote cancer prevention, and resources to advance research for a cure. What started with friends and family grew into a community. The Summits Podcast is an extension of that community. Our stories are what bring us together. Artists, athletes, doctors, business people - we're all family members, community leaders, and activists. Everyone has a story. Anyone can inspire. No one battles alone. Join the conversation. Let's climb the summit together.

Clinicians in the RUSH Cancer Center are continually providing tailored cancer treatment to their patients. In today's episode with Jessica Slostad, MD, a breast oncologist in the RUSH University System for Health, she profiles one possible, future avenue for personalized medicine--organoid drug screening. Although they are still being evaluated, tumor organoid drug screening may play a key role in the evolution of personalized cancer care. This type of screening could help clinicians test the effectiveness and side effects of therapies prior to giving them to patients. Later in the episode, she profiles the ways she treats women with pregnancy-associated breast cancer, along with the unique challenges mothers and their babies encounter during treatment. Dr. Slostad is an assistant professor of Medicine in the Division of Hematology, Oncology and Cellular Therapy at RUSH and specializes in breast cancer management. Her research interests include clinical and translational research with a focus on precision oncology and organoid technology. “As we get more data and if [that data] supports the hypothesis that tumor organoids can be used as a drug screen to predict response, we would eventually look to see if we can use the tumor organoid to pick which therapy for the patient. Our data is not there yet; we first need to establish that there is concordance between the drug screen and what the patient is getting.” CME Link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/490159/

Smartphones in Schools Triggers Safety Scare.  Biden Backs 'Trust Mark' for Smart Devices.  Proliferating Pricey Pet-Tech Products.  Cardiff's Cutting-Edge AI Contributes to Breast Cancer Care.  Deepfake Dilemma as Deceptive Clips Are Distorting Memories.  Intel's FakeCatcher Faces Fakes.  Points Scam Pounces on Popular Loyalty Programs.  Google's Green Routes Reduce Roadway Emissions.  Australian Scientist's UV Innovation Delivers Clean Water With a Sticker. 

Black, Indigenous and People of Colour face healthcare disparities in many forms, including in their experience of cancer. The reasons are complex and involve numerous economic, social and biological factors. This was the experience of Michelle Audoin, a Black woman diagnosed with metastatic breast cancer at age 40. Asked to decide whether or not she wanted reconstructive breast surgery, she could find no images of Black women to help her make an informed choice. With the aim of raising awareness of the experiences of Black, Indigenous and People of Colour living with breast cancer, Michelle came up with the idea of Uncovered, A Breast Recognition Project, a resource created in collaboration with ReThink Breast Cancer, an organisation based in Canada. Through powerful photographs and stories of BIPOC living with breast cancer, Uncovered seeks to shine a light on these inequities, and help educate all people about the unmet needs of the Black, Indigenous and People of Colour community. We're speaking with Michelle Audoin, the creator of Uncovered, and MJ DeCoteau, Founder and Executive Director of Rethink Breast Cancer. Hosted on Acast. See acast.com/privacy for more information.

Today, we talk to Christine Teal, MD, the Chief of Breast Surgery at The George Washington University Hospital, and Rachel Brem, MD, vice chair of Radiology and director of the Breast Imaging & Intervention Center. They are the authors of “No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You.” Published in May 2023, it's a life-saving and empowering guide to understanding breast cancer detection, prevention, and treatment options. Dr. Teal and her colleagues have developed a cutting-edge, holistic, patient-focused Breast Care Center that integrates complementary medicine with the latest technology and surgical innovations. Dr. Brem is an internationally known breast cancer expert who has been instrumental in developing and implementing new technologies to improve breast cancer detection. She is also deeply motivated to eliminate health care disparities. ◘ Related Content: No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You amzn.to/3JdXtyP ◘ Transcript: amzn.to/3JdXtyP ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

In a paper published in JAMA Oncology, Dr. Erik Eckert, of Stanford, and his colleagues found that LGBTQ people with breast cancer faces delays in diagnosis and have a three times higher risk of recurrence than heterosexual cisgender people. Listen to the episode to hear Dr. Eckhert discuss: the discrimination LGBTQ+ people face when going to doctor's appointments and other healthcare visits why he decided to do the study and what the results were the next steps for this research how LGBTQ+ people can make sure they're getting the best and most appropriate care, whether it's for breast cancer or another issue

Why are Black women 40 percent more likely to die from breast cancer than white women? And why is it such a challenge to make clinical trials reflect everyone who faces breast cancer? That's what Dr. Sonya Reid and her team are working to uncover by addressing disparities in breast cancer diagnosis and treatment through research. Dr. Reid is an assistant professor of hematology/oncology at Vanderbilt University Medical Center. Her three-year Conquer Cancer–BCRF grant was made possible by The Estée Lauder Companies' Charitable Foundation Awards.

Host: Jennifer Caudle, DO Guest: Stephanie Graff, MD Endocrine resistance and toxicities are just a few of the many challenges facing clinicians who treat patients with ER+/HER2- advanced breast cancer. So what strategies can we use to better address these challenges and unmet needs? Joining Dr. Jennifer Caudle to share her approach is Dr. Stephanie Graff, Director of the Breast Oncology Program at Lifespan Cancer Institute in Providence, Rhode Island.

BJ Kissel sits down with Kansas City Chiefs 2022 NFL Fan of the Year Nominee Dr. Amy Patel to talk about her nomination and her work in breast cancer care and access in the Kansas City area. — Compete against KCSN hosts and other KCSN supporters in our exclusive DraftKings Daily Fantasy league for just $5. Only 50 players are allowed per week, so act now! https://dkn.gs/r/gj0tcTskQEqlep-O0Zhh6Q — Download the DraftKings Sportsbook App NOW and sign up with promo code KCSN! https://apps.apple.com/us/app/draftkings-sportsbook-casino/id1375031369 — Subscribe to the KCSN Daily substack for film reviews, exclusive podcasts, KC Draft guide, discounts and access, giveaways, merch drops and more at https://kcsn.substack.com/subscribe — You can look good while supporting the network by copping some NEW KCSN merch in collaboration with our friends at Charlie Hustle. https://www.charliehustle.com/collections/kc-sports-network  FOLLOW US ON: Facebook - https://www.facebook.com/KCSportsNetwork Instagram - https://www.instagram.com/kcsports.network/ Twitter - https://twitter.com/KCSportsNetwork Substack - https://kcsn.substack.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Shanu Modi led DESTINY-Breast04, a groundbreaking study that resulted in FDA approval of a promising treatment that can improve survival for nearly 50% of all patients with metastatic breast cancer today. This Conquer Cancer grant recipient talks about the importance of patient participation in clinical trials, the necessity of donor-funded research, and the bright future of breast cancer care. 

Joanna Morales and Loriana Hernandez-Aldama talk about the common issues people face when paying for cancer care and offer solutions for them. Listen to the podcast to hear Joanna and Loriana discuss: the four most common issues people face when paying for cancer care their personal experiences helping people overcome financial issues advice on how to solve financial issues resource recommendations for help with financial issues

Hello and welcome to today's latest episode of OC Talks Podcast by Oncology Central. My name is Jade Parker, Senior Editor of Oncology Central, and I am joined by Volkmar Mϋller from University Medical Center Hamburg-Eppendorf in Germany. Today we are going to discuss HER2-positive breast cancer including the unmet needs of the disease, and our hopes for the future.

In this episode of the BayCare Clinic podcast, Dr. Natalie Luehmann, breast surgeon with Aurora BayCare General & Vascular Surgery, discusses the impact of specialized and comprehensive breast cancer care for patients. She talks about options available to patients after a breast cancer diagnosis and the approach to collaborative care she and her colleagues take and what impact that has on the patient experience. To watch the discussion with Dr. Luehmann, clickhere: https://www.facebook.com/watch/live/?ref=watch_permalink&v=406021157882151 For more information about BayCare Clinic visit: https://baycare.clinic/2SkVAoD For more information about Aurora BayCare General & Vascular Surgery, visit: https://baycare.clinic/3b1qkI8 For more information about Dr. Natalie Luehmann visit: https://baycare.clinic/3xAZPBg Find BayCare Clinic on Facebook: https://baycare.clinic/2g4hDFB Find BayCare Clinic on Twitter: https://baycare.clinic/2uMlLTW Find BayCare Clinic on LinkedIn: https://baycare.clinic/2SkC0Zx Find BayCare Clinic on YouTube: https://baycare.clinic/2vGO7YT

Many extraordinary new treatments, diagnostic tests, and procedures for breast cancer patients have been introduced in the past decade—and more are needed and sure to come. But researchers are still exploring ways to improve health disparities in cancer care delivery, quality of care, and quality of life for patients and thrivers. In this latest episode, we spoke to BCRF Investigator since 2008, Dr. Dawn Hershman, on ways to shrink these gaps in care.

Dr D'Abreo discusses adverse effects such as fatigue, nausea and vomiting, and interstitial lung disease, shares advice on establishing an open channel of communication with patients, and highlights preventive and proactive management strategies for treatment-related adverse effects.

18. Naturopathic physician Katrina Bogdon joins me on this episode to discuss evidence-based integrative approaches for breast cancer. She is a wealth of information for naturopathic integrative oncology and provides compassionate care with a level of excellence that is hard to find. In this episode she shares how to navigate the challenges of being diagnosed with breast cancer and where to find evidence-based therapies. You will also learn more about her integrative program for people undergoing breast cancer treatment called The Missing Piece.  You can learn more about her services at Our Healing RootsResource mentioned: Beyond Conventional Cancer Therapies DISCLAIMER: Katrina is not licensed in the state of Missouri and works as a Naturopathic Integrative Consultant.